Morphic to Present at the Jefferies Global Healthcare Conference
Jun 6, 2023 · A live webcast of the presentation will be available on the Investor section of the Morphic website, or at the link here. An archived replay will be available on the company’s …
SEC Filing – Morphic Therapeutic
Morphic Holding, Inc. presented the investor presentation attached hereto as Exhibit 99.1 at the Jefferies Next Generation IBD Therapeutics Virtual Summit on September 23, 2020.
SEC Filing – Morphic Therapeutic
Pursuant to Rule 462 (b) under the Securities Act of 1933, as amended ( Securities Act ), Morphic Holding, Inc. ( Registrant ) is filing this Registration Statement on Form S-1 (this Registration …
Chris Matranga – Morphic Therapeutic
Morphic is leveraging its structural biology expertise and medicinal chemistry capabilities to develop small molecule therapeutic candidates against non-integrin targets including TL1-A …
Morphic Holding, Inc. (the “Company”) was formed under the laws of the State of Delaware in August 2014. The Company is a biopharmaceutical company applying proprietary insights into …